Market Overview:
The global combination drugs diagnostic market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, cardiovascular diseases, and other diseases across the globe. In addition, the growing demand for combination drugs for the treatment of various disorders is also contributing to the growth of this market. The global combination drugs diagnostic market can be segmented on the basis of type into cardiovascular catheters, antimicrobial catheters, urological catheters, thermodilution catheters, oximetry catheters, bone graft substitutes, wound drainage catheters and peripheral vascular stents. The cardiovascular segment is expected to account for a major share in this market owing to rising incidence rates of cardiovascular diseases across the globe.
Product Definition:
A combination drug is a pharmaceutical drug that is composed of two or more active ingredients. The use of combination drugs can improve the efficacy and tolerability of individual medications, as well as decrease the risk for adverse effects.
Cardiovascular Catheters:
The cardiovascular catheters are used to treat heart diseases and certain other disorders. The growth factor in combination drugs diagnostic market is expected to grow at a rapid pace during the forecast period due to rising incidences of Cardiovascular Diseases (CVDs) globally. According to the World Health Organization, CVDs contribute towards around 31% of global deaths; more than cancer and diabetes combined.
Antimicrobial Catheters:
Antimicrobial catheters are used in combination drugs diagnostic market to treat infections. These catheters can be used with local anesthetics, antibiotics, and anti-inflammatory drugs. They are also useful for treating diseases related to urinary tract and female reproductive system. Antimicrobial catheter is a hollow tube made up of plastic or metal which is inserted into the body via vein; it contains antimicrobial solution that targets specific bacteria causing infection at a specific site.
Application Insights:
Treatment of infectious diseases dominated the global combination drugs diagnostic market in 2017, owing to the rising prevalence of multi-drug resistant bacteria. The increasing number of patients suffering from infections and the complexity associated with their treatment are factors that drive this segment. According to a study published by WHO in 2018, around 10 million people die each year due to infections and related conditions. Thus, an increase in disease incidence leads to growth in demand for combination drugs diagnostic devices as they help identify different types of infection including pneumonia, tuberculosis, HIV/AIDS etc.
The application segment includes treatment of cardiovascular diseases, treatment of respiratory disorders such as asthma and COPD along with other diseases such as diabetes mellitus type 1 & 2 and kidney stones among others which collectively accounted for a revenue share below 15% globally in 2017 owing to low usage rates compared with infectious disease diagnosis techniques across all regions combined.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of healthcare facilities, favorable reimbursement policies, and increasing government initiatives for Combination Drug-resistant tuberculosis diagnosis. In addition, high incidence rate of CVDs and growing geriatric population are also expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising prevalence of chronic diseases such as cancer & diabetes which requires combination therapy for treatment along with an increase in healthcare expenditure by governments as well as patients’ families thus driving demand for diagnostic products used across various medical settings such as hospitals & clinics, home care centers & pharmacies among others. Moreover it has been observed that majority of new cases diagnosed annually worldwide are from Asian countries like China (23%) India (19%) Japan (15%), Indonesia (13%), South Korea (12%).
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. As a result, there is an increased demand for combination drugs that can effectively treat these conditions.
- Advances in diagnostic technologies: The development of new and innovative diagnostic technologies has led to a better understanding of the underlying causes of various diseases. This has helped in the development of more effective combination drugs that can target these causes specifically.
- Growing awareness about preventive healthcare: There is a growing awareness among people about the importance of preventive healthcare measures. This has led to an increase in demand for combination drugs that can help prevent the onset or progression of various chronic diseases.
Scope Of The Report
Report Attributes
Report Details
Report Title
Combination Drugs Diagnostic Market Research Report
By Type
Cardiovascular Catheters, Antimicrobial Catheters, Urological Catheters, Thermodilution Catheters, Oximetry Catheters, Bone Graft Substitutes, Wound Drainage Catheters, Peripheral Vascular Stent
By Application
Treatment of Infectious Diseases, Treatment of Cardiovascular Diseases, Treatment of Psychiatric Disorders, Treatment of Respiratory Disorders, Treatment of Other Diseases
By Companies
Biometrix Medical, Zimmer, Smith & Nephew, Stryker, Medtronic, Boston Scientific, St.Jude Medical, Wright Medical, Roche Diagnostics, Bristol Myers Squibb, Novartis, Arrow, Medtronic, IntegraLifeSciences, DePuy Orthopaedics, Cordis, Biomet Orthopaedics, Angiotech Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
138
Number of Tables & Figures
97
Customization Available
Yes, the report can be customized as per your need.
Global Combination Drugs Diagnostic Market Report Segments:
The global Combination Drugs Diagnostic market is segmented on the basis of:
Types
Cardiovascular Catheters, Antimicrobial Catheters, Urological Catheters, Thermodilution Catheters, Oximetry Catheters, Bone Graft Substitutes, Wound Drainage Catheters, Peripheral Vascular Stent
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Treatment of Infectious Diseases, Treatment of Cardiovascular Diseases, Treatment of Psychiatric Disorders, Treatment of Respiratory Disorders, Treatment of Other Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biometrix Medical
- Zimmer
- Smith & Nephew
- Stryker
- Medtronic
- Boston Scientific
- St.Jude Medical
- Wright Medical
- Roche Diagnostics
- Bristol Myers Squibb
- Novartis
- Arrow
- Medtronic
- IntegraLifeSciences
- DePuy Orthopaedics
- Cordis
- Biomet Orthopaedics
- Angiotech Pharmaceuticals
Highlights of The Combination Drugs Diagnostic Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cardiovascular Catheters
- Antimicrobial Catheters
- Urological Catheters
- Thermodilution Catheters
- Oximetry Catheters
- Bone Graft Substitutes
- Wound Drainage Catheters
- Peripheral Vascular Stent
- By Application:
- Treatment of Infectious Diseases
- Treatment of Cardiovascular Diseases
- Treatment of Psychiatric Disorders
- Treatment of Respiratory Disorders
- Treatment of Other Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Combination Drugs Diagnostic Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Combination drugs diagnostic is a term used to describe the use of two or more medications in order to treat a particular medical condition.
Some of the key players operating in the combination drugs diagnostic market are Biometrix Medical, Zimmer, Smith & Nephew, Stryker, Medtronic, Boston Scientific, St.Jude Medical, Wright Medical, Roche Diagnostics, Bristol Myers Squibb, Novartis, Arrow, Medtronic, IntegraLifeSciences, DePuy Orthopaedics, Cordis, Biomet Orthopaedics, Angiotech Pharmaceuticals.
The combination drugs diagnostic market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Combination Drugs Diagnostic Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Combination Drugs Diagnostic Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Combination Drugs Diagnostic Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Combination Drugs Diagnostic Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Combination Drugs Diagnostic Market Size & Forecast, 2020-2028
4.5.1 Combination Drugs Diagnostic Market Size and Y-o-Y Growth
4.5.2 Combination Drugs Diagnostic Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Cardiovascular Catheters
5.2.2 Antimicrobial Catheters
5.2.3 Urological Catheters
5.2.4 Thermodilution Catheters
5.2.5 Oximetry Catheters
5.2.6 Bone Graft Substitutes
5.2.7 Wound Drainage Catheters
5.2.8 Peripheral Vascular Stent
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Treatment of Infectious Diseases
6.2.2 Treatment of Cardiovascular Diseases
6.2.3 Treatment of Psychiatric Disorders
6.2.4 Treatment of Respiratory Disorders
6.2.5 Treatment of Other Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Combination Drugs Diagnostic Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Combination Drugs Diagnostic Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Cardiovascular Catheters
9.6.2 Antimicrobial Catheters
9.6.3 Urological Catheters
9.6.4 Thermodilution Catheters
9.6.5 Oximetry Catheters
9.6.6 Bone Graft Substitutes
9.6.7 Wound Drainage Catheters
9.6.8 Peripheral Vascular Stent
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Treatment of Infectious Diseases
9.10.2 Treatment of Cardiovascular Diseases
9.10.3 Treatment of Psychiatric Disorders
9.10.4 Treatment of Respiratory Disorders
9.10.5 Treatment of Other Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Cardiovascular Catheters
10.6.2 Antimicrobial Catheters
10.6.3 Urological Catheters
10.6.4 Thermodilution Catheters
10.6.5 Oximetry Catheters
10.6.6 Bone Graft Substitutes
10.6.7 Wound Drainage Catheters
10.6.8 Peripheral Vascular Stent
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Treatment of Infectious Diseases
10.10.2 Treatment of Cardiovascular Diseases
10.10.3 Treatment of Psychiatric Disorders
10.10.4 Treatment of Respiratory Disorders
10.10.5 Treatment of Other Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Cardiovascular Catheters
11.6.2 Antimicrobial Catheters
11.6.3 Urological Catheters
11.6.4 Thermodilution Catheters
11.6.5 Oximetry Catheters
11.6.6 Bone Graft Substitutes
11.6.7 Wound Drainage Catheters
11.6.8 Peripheral Vascular Stent
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Treatment of Infectious Diseases
11.10.2 Treatment of Cardiovascular Diseases
11.10.3 Treatment of Psychiatric Disorders
11.10.4 Treatment of Respiratory Disorders
11.10.5 Treatment of Other Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Cardiovascular Catheters
12.6.2 Antimicrobial Catheters
12.6.3 Urological Catheters
12.6.4 Thermodilution Catheters
12.6.5 Oximetry Catheters
12.6.6 Bone Graft Substitutes
12.6.7 Wound Drainage Catheters
12.6.8 Peripheral Vascular Stent
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Treatment of Infectious Diseases
12.10.2 Treatment of Cardiovascular Diseases
12.10.3 Treatment of Psychiatric Disorders
12.10.4 Treatment of Respiratory Disorders
12.10.5 Treatment of Other Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Cardiovascular Catheters
13.6.2 Antimicrobial Catheters
13.6.3 Urological Catheters
13.6.4 Thermodilution Catheters
13.6.5 Oximetry Catheters
13.6.6 Bone Graft Substitutes
13.6.7 Wound Drainage Catheters
13.6.8 Peripheral Vascular Stent
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Treatment of Infectious Diseases
13.10.2 Treatment of Cardiovascular Diseases
13.10.3 Treatment of Psychiatric Disorders
13.10.4 Treatment of Respiratory Disorders
13.10.5 Treatment of Other Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Combination Drugs Diagnostic Market: Competitive Dashboard
14.2 Global Combination Drugs Diagnostic Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biometrix Medical
14.3.2 Zimmer
14.3.3 Smith & Nephew
14.3.4 Stryker
14.3.5 Medtronic
14.3.6 Boston Scientific
14.3.7 St.Jude Medical
14.3.8 Wright Medical
14.3.9 Roche Diagnostics
14.3.10 Bristol Myers Squibb
14.3.11 Novartis
14.3.12 Arrow
14.3.13 Medtronic
14.3.14 IntegraLifeSciences
14.3.15 DePuy Orthopaedics
14.3.16 Cordis
14.3.17 Biomet Orthopaedics
14.3.18 Angiotech Pharmaceuticals
